Health News

What is neutropenia? What causes neutropenia?

Date: Aug-28-2013
Neutropenia is a blood condition, a granulocyte disorder, that characterized by a deficiency of neutrophils, a type of white blood cell that defends the body against bacterial and fungal infections. Granulocytes are a category of white blood cells. They are made in bone marrow. They contain microscopic granules with proteins (enzymes) that digest invading bacteria, viruses, fungi and parasites and play a key role in our immune system response...

Real World Data & Analytics Forum, November 12 - 13, 2013 at the Princeton Marriott in Forrestal, Princeton, N.J.

Date: Aug-28-2013
EXL Pharma provides a much-needed forum for pharma and medical device professionals to discuss real world solutions to pharma's big data challenges in clinical trials, R&D and business intelligence ExL Pharma, the industry leader in educational life science conferences, have announced the lineup for its Real World Data & Analytics Forum, taking place November 12 - 13, 2013 at the Princeton Marriott in Forrestal, Princeton, N.J...

Scientists discover drug that could combat migraines

Date: Aug-28-2013
Researchers have discovered a new compound that could potentially treat migraines by blocking light sensors in the eyes, according to a study published in the journal Nature Chemical Biology. Researchers from the Salk Institute for Biological Studies have found that a series of compounds called opsinamides can block a receptor in the eye called melanopsin - a receptor found in neurons connecting the eyes and the brain. The researchers discovered 10 years ago that melanopsin is responsible for sensing light on its own, away from normal vision...

'Majority' of stroke patients might have undiagnosed attention disorders

Date: Aug-28-2013
The majority of stroke patients may have attention disorders, most of which are not diagnosed, according to a study published in the journal Neurology. Researchers from Imperial College London in the UK analyzed 110 patients who were being treated for stroke at London's Charing Cross Hospital, alongside 62 participants who had not suffered from stroke. Five of the stroke patients had already been diagnosed with an attention disorder called "neglect" - a deficit of attention and awareness in one side of the body...

Salt intake controlled by brain, not diet

Date: Aug-28-2013
Reducing salt consumption has been recommended to help manage cardiovascular disease and high blood pressure, based on the idea that our sodium intake exceeds the needs of our body. But a study led by scientists at UC-Davis lends credence to a recent finding that sodium intake is controlled by networks in the brain, not by the salt we consume. The current US sodium guidelines for healthy individuals are no more than 2,300 mg per day, while for those at risk of heart disease, the recommended level is no more than 1,500 mg per day...

4th International Conference on Clinical & Experimental Ophthalmology, June 23-25, 2014, New Orleans, USA

Date: Aug-28-2013
OMICS Group invites all participants across the globe to attend the 4th International Conference on Clinical & Experimental Ophthalmology to be held on June 23-25, 2014 at New Orleans, USA. Ophthalmology-2014 is a remarkable event which brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostic companies, leading universities and clinical research institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe...

CE Mark approval for Seralite® announced, the world's first point-of-care diagnostic device for multiple myeloma

Date: Aug-28-2013
Serascience Limited, a specialist cancer diagnostics company established by a joint venture between Abingdon Health and the University of Birmingham, announces the receipt of European CE Mark approval for the commercial sale of Seralite®, its proprietary point-of-care diagnostic device for multiple myeloma. The approval allows the Company to market the world's first point-of-care diagnostic device in multiple myeloma in the 30 countries that comprise the European Union (EU) and the European Free Trade Association (EFTA)...

Target Meeting's 3rd World Diabetes & Obesity Online Conference, September 19-21, 2013

Date: Aug-28-2013
A Free Virtual Diabetes & Obesity Conference at Targetmeeting.com featuring 60+ live presentations from academic and industry experts around the world. The 15 sessions (60+ oral presentations), which will be spread over three days will discuss Clinical Obesity, Obesity Basic Research, Preventive Diabetes Medicine, Clinical Diabetes, Diabetes Basic Research, and many more. Attendees can earn the free Certificates of Attendance. Computer and internet connection are required. Do not need any special equipment or software...

Target Meeting's 3rd World Cardiovascular Online Conference, September 16-18, 2013

Date: Aug-28-2013
A Free Virtual Cardiovascular Conference at Targetmeeting.com featuring 55 live presentations from academic and industry experts around the world. The 12 sessions, which will be spread over three days will discuss Cardiovascular Disease Epidemiology, Cardiovascular Clinical, Preventive Cardiovascular Medicine, Vascular Diseases, Cardiovascular Research, Heart Diseases, and many more. Attendees can earn the free Certificates of Attendance. Computer and internet connection are required. Do not need any special equipment or software...

'Shapeshifting' computer program will open up drug discovery for tricky disease targets

Date: Aug-28-2013
A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists. The Shapeshifting Inspired Discovery (SID) program decodes the structures of proteins in our cells that scientists suspect may hold the key to new treatments. The program can rapidly analyse the complicated shapes and identify how the proteins might be "shapeshifted" by drugs...